Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002088341A3 P450 proteins
08/14/2003WO2002083902A3 Adenovirus serotype 30 (ad30) fiber protein and uses thereof
08/14/2003WO2002083176A3 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
08/14/2003WO2002064620A3 Metal-binding compounds and uses therefor
08/14/2003WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/14/2003WO2002057795A3 Methods of diagnosis and treatment of osteoporosis
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002051439A3 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002050117A3 G-proteins coupled receptor proteins and nucleic acids encoding same
08/14/2003WO2002046415A3 Polynucleotide and polypeptide sequences of putative transporters and ion channells
08/14/2003WO2002043807A3 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
08/14/2003WO2002042422A3 Molecular interactions in hematopoietic cells
08/14/2003WO2002038601A3 Foggy
08/14/2003WO2002038142A3 Serotonergic compositions and methods for treatment of mild cognitive impairment
08/14/2003WO2002030445A3 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002028420A3 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
08/14/2003WO2002026779A3 A fibrin/fibrinogen-binding conjugate
08/14/2003WO2002024887A3 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
08/14/2003WO2002024867A3 Novel compositions and methods for lymphoma and leukemia
08/14/2003WO2002024735A3 Peptide inhibitors of hiv entry
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002020475A3 Inhibitors of serine protease activity of matriptase or mtsp1
08/14/2003WO2002016584A3 Process for the preparation of neutrophil inhibitory factor
08/14/2003WO2002014351A3 α7 NICOTINIC RECEPTOR PEPTIDES AS LIGANDS FOR β AMYLOID P EPTIDES
08/14/2003WO2002013866A9 Stimulating neutrophil function to treat inflammatory bowel disease
08/14/2003WO2002012336A3 TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001092292A3 Ghrelin analogs
08/14/2003WO2001090421A3 Method of detecting inflammatory lung disorders
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003WO2001055198A9 Dermo- and gastro-specific sphingolipid activator
08/14/2003US20030154504 Methods and compositions for modulating carbohydrate metabolism
08/14/2003US20030154032 Methods and compositions for diagnosing and treating rheumatoid arthritis
08/14/2003US20030153849 Method and apparatus for connective tissue treatment
08/14/2003US20030153739 Formed via cloning and expressing cDNA, then detecting missense mutations with immunoassay
08/14/2003US20030153738 Homologs of bacterial AlkB gene (hABH); receptor binding assay; for repairing alkylated DNA, preventing/treating cell death/cancer
08/14/2003US20030153733 Antibiotic resistant drug screening; vaccines
08/14/2003US20030153732 Novel polypepetide
08/14/2003US20030153731 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
08/14/2003US20030153730 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
08/14/2003US20030153727 Controlling protein levels in eucaryotic organisms
08/14/2003US20030153526 Compositions contain antisense oligonucleotides that hybridize to Grb2 and Crkl nucleic acids, gene products of which are known to interact with tumorigenic protein bcr-abl
08/14/2003US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153522 Rat pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
08/14/2003US20030153521 Nucleic acid treatment of diseases or conditions related to levels of Ras
08/14/2003US20030153520 Inside cells, such as those involving fusion events and in particular those involving exocytic events, in particular relates to positive and negative regulation of any tetanus neurotoxin (TeNT)-resistant pathway inside a cell
08/14/2003US20030153518 Activation and inhibition of the immune system
08/14/2003US20030153511 Administering a dose of multiple function protein 14 (MFP 14), animal extracts from liver
08/14/2003US20030153509 Inhibiting the dipeptidylpeptidase proteolysis of Glucagon-like peptide, by administering a dipeptides consisting Pro-Pro, Ala-Pro, and (D)-Ala-(L)-Ala; treating metabolism disorders, diabetes, obesity, atherosclerosis
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures
08/14/2003US20030153505 Anticarcinogenic agents for treating cancer; pentapeptides, hexapeptides, heptapeptides, oligopeptides
08/14/2003US20030153504 Antiinflammatory agents selects from a group of tetrapeptides, hexapeptides, octapeptides, oligopeptides, polypeptides
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153502 A water-soluble polypeptide having hydrophobic side chains, for use as bactericides treating infections, detoxification of endotoxin, cell antiproliferative agents, antagonist of tumor necrosis factor
08/14/2003US20030153501 Methods and compositions for treating ocular disorders
08/14/2003US20030153500 Use of EGF to inhibit pathogenic infections
08/14/2003US20030153499 Isolated nucleic acid molecules encoding polypeptides; genetic engineering antiproliferative agents for regulating cell differentiation, immunomodulators
08/14/2003US20030153498 An isolated polynucleotide encoding the polypeptide, treating infections, viral diseases, anorexia, bulimia, asthma, Parkinson's diseases, hypotension, hypertension, cancers, osteoporosis, angina pectoris, cardiovascular disorders
08/14/2003US20030153497 A polypeptides and polynucleotides encoding the polypeptides, for obesity, insulin resistance, type 2 diabetes, cachexia
08/14/2003US20030153496 Increasing the viscosity of mucin with trefoil factors
08/14/2003US20030153495 Treatment of inflammatory bowel disease using growth factors
08/14/2003US20030153494 Somatostatin agonist; for binding one or more of human somatostatin subtype receptors -1, -2, -3 and -5; treating diseases such as Cushings Syndrome, gonadotropinoma, hyperparathyroidism, Paget's disease
08/14/2003US20030153493 Combination cancer therapy
08/14/2003US20030153492 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
08/14/2003US20030153491 Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153489 Agent for preventing and/or treating multiple organ failure
08/14/2003US20030153487 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
08/14/2003US20030153097 Modulation of COP9 signalsome isopeptidase activity
08/14/2003US20030153081 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/14/2003US20030153075 TGF-beta-specific covalently closed antisense molecule
08/14/2003US20030153072 Culturing spermatogonial stem cells in the presence of BMP8 (bone morphogenetic protein-8) or a biologically active fragment or an agonist to effect proliferation of mammal spermatogonial stem cells
08/14/2003US20030153064 A novel member of disintegrin Proteases, used for delivery and therapeutics
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153062 Twenty-one butyrylcholinesterase variant polypeptides having increased cocaine hydrolysis activity comparted to naturally occurring human butyrylcholinesterase
08/14/2003US20030153056 Glycosyltransferase proteins
08/14/2003US20030153048 Novel proteins and methods for producing the proteins
08/14/2003US20030153047 AIB1, a novel steroid receptor co-activator
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030153043 Method for the production of non-immunogenic proteins
08/14/2003US20030153041 Controlling calcium channel blockers; central nervous system disorders, gastrointestinal disorders, cardiovascular disorders, muscular disorders
08/14/2003US20030153040 Central nervous system disorders; antiinflammatory agents; antidiabetic agents; anticancer agents; hybrid polynucleotide
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153016 PSCA: prostate stem cell antigen
08/14/2003US20030153003 Growth hormone variants
08/14/2003US20030153000 Genetic engineering; culture product; recovering
08/14/2003US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152989 Genetic engineering; therapy for liver disease; antitumor agents
08/14/2003US20030152983 Desaturase
08/14/2003US20030152977 Which is highly expressed in brain, spinal cord and pituitary, for analyzing neuological systems and conditions; membrane proteins
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152971 Methods and compositions for detecting target sequences
08/14/2003US20030152970 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
08/14/2003US20030152963 Comprises peroxisome proliferator activated receptors; for treating accompanying conditions such as obesity, retinal degeneration, and disorders affecting the nervous system, heart, and/or kidneys
1 ... 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 ... 3163